3-Bromo-6-methyl-5H-pyrrolo[3,4-b]pyridin-7(6H)-one
95%
- Product Code: 87360
CAS:
1254319-55-5
| Molecular Weight: | 227.06 g./mol | Molecular Formula: | C₈H₇BrN₂O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD20229834 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure makes it a valuable intermediate in the creation of biologically active molecules, especially those targeting neurological disorders and cancer. Researchers leverage its unique pyrrolopyridine core to design compounds that interact with specific enzymes or receptors, potentially leading to new therapeutic agents. Additionally, it is explored in medicinal chemistry for its potential to modulate protein-protein interactions, which are critical in disease pathways. Its bromo and methyl groups offer versatility in further chemical modifications, enabling the development of diverse analogs for biological screening.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $757.99 |
+
-
|
| 0.250 | 10-20 days | $1,219.21 |
+
-
|
3-Bromo-6-methyl-5H-pyrrolo[3,4-b]pyridin-7(6H)-one
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure makes it a valuable intermediate in the creation of biologically active molecules, especially those targeting neurological disorders and cancer. Researchers leverage its unique pyrrolopyridine core to design compounds that interact with specific enzymes or receptors, potentially leading to new therapeutic agents. Additionally, it is explored in medicinal chemistry for its potential to modulate protein-protein interactions, which are critical in disease pathways. Its bromo and methyl groups offer versatility in further chemical modifications, enabling the development of diverse analogs for biological screening.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :